{
    "clinical_study": {
        "@rank": "85868", 
        "brief_summary": {
            "textblock": "To evaluate the safety of zalcitabine (dideoxycytidine; ddC) alone and in combination with\n      zidovudine (AZT) versus AZT alone when administered to asymptomatic patients with a CD4\n      count = or < 200 cells/mm3 and symptomatic patients with a CD4 count = or < 300 cells/mm3.\n      To compare the effectiveness of ddC alone and in combination with AZT versus AZT alone.\n\n      ddC has been shown to demonstrate an antiviral effect. AZT has been shown to significantly\n      decrease mortality and reduce the frequency of opportunistic infections in patients with\n      AIDS or advanced ARC. After 1 year of AZT therapy, the effectiveness tends to diminish and\n      patients progress with more opportunistic infections and higher mortality rates. Because of\n      the demonstrated antiviral activity, absence of hematologic toxicity, and lack of cross\n      tolerance in laboratory studies of ddC, a study to investigate the long-term effectiveness\n      of ddC in patients with HIV infection who have received AZT therapy is warranted."
        }, 
        "brief_title": "A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy", 
        "completion_date": {
            "#text": "May 1993", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "ddC has been shown to demonstrate an antiviral effect. AZT has been shown to significantly\n      decrease mortality and reduce the frequency of opportunistic infections in patients with\n      AIDS or advanced ARC. After 1 year of AZT therapy, the effectiveness tends to diminish and\n      patients progress with more opportunistic infections and higher mortality rates. Because of\n      the demonstrated antiviral activity, absence of hematologic toxicity, and lack of cross\n      tolerance in laboratory studies of ddC, a study to investigate the long-term effectiveness\n      of ddC in patients with HIV infection who have received AZT therapy is warranted.\n\n      Patients are randomly assigned to 1 of 3 treatment groups. In study arm 1, patients receive\n      AZT plus ddC placebo. In study arm 2, patients receive ddC plus AZT placebo capsules. In\n      study arm 3, patients receive ddC plus AZT. Patients are seen every other week for first 8\n      weeks and monthly thereafter. Patients are stratified by HIV disease status, length of time\n      receiving AZT, and systemic or local Pneumocystis carinii pneumonia (PCP) prophylaxis.\n      Patients who reach a clinical AIDS-defining endpoint are offered open-label combination\n      therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Required:\n\n          -  Zidovudine (AZT) = or > 300 mg/day for 6 weeks prior to study entry.\n\n        Allowed:\n\n          -  Chemoprophylaxis for Pneumocystis carinii pneumonia (PCP), candidiasis, and herpes.\n\n          -  21 day course of adjuvant systemic corticosteroids for moderate to severe PCP.\n\n          -  Maintenance treatment with pyrimethamine, sulfadiazine, amphotericin, fluconazole,\n             ketoconazole, acyclovir, ganciclovir, or medications for tuberculosis or\n             Mycobacterium avium for patients who have recovered from toxoplasmosis,\n             cryptococcosis, candidiasis, herpes virus infections, cytomegalovirus infections,\n             tuberculosis or Mycobacterium avium intracellulare.\n\n          -  14 day course of metronidazole.\n\n          -  Erythropoietin and megace if clinically indicated.\n\n          -  Isoniazid if patient has no peripheral neuropathy at entry and is taking pyridoxine =\n             or > 50 mg/day concomitantly.\n\n          -  Phenytoin if patient has < grade 2 peripheral neuropathy at entry and has been stable\n             on phenytoin = or > 3 months.\n\n        Patients must have:\n\n          -  Ability and willingness to give informed consent.\n\n          -  Written informed consent from a parent or guardian if < 18 years old.\n\n          -  Been tolerating zidovudine (AZT) therapy.\n\n          -  Diagnosis of HIV infection.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Kaposi's sarcoma or other malignancy requiring therapy.\n\n          -  Active opportunistic infections.\n\n          -  Peripheral neuropathy as manifested by complaints of moderate pain, burning,\n             numbness, or tingling in hands/arms or feet/legs; moderate sensory deficit in the\n             upper or lower extremities; or motor weakness in the upper or lower extremities.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Other experimental medications.\n\n          -  Other anti-HIV drugs.\n\n          -  Biologic response modifiers.\n\n          -  Cytotoxic chemotherapy.\n\n          -  Drugs that could cause peripheral neuropathy including phenytoin not specifically\n             allowed, hydralazine, nitrofurantoin, vincristine, cisplatinum, dapsone, disulfiram,\n             and diethyldithiocarbamate.\n\n        Concurrent Treatment:\n\n        Excluded:\n\n          -  Radiation therapy.\n\n        Patients with the following are excluded:\n\n          -  Active opportunistic infection.  Must have ended acute therapy at least 14 days prior\n             to study entry.\n\n          -  Peripheral neuropathy = or > grade 2.\n\n          -  History of intolerance to 500 to 600 mg/day of zidovudine (AZT) as manifested by the\n             same recurrent grade 3 toxicity requiring dose interruptions and dose reductions to <\n             500 mg/day or any prior grade 4 toxicity.\n\n          -  Prior development of peripheral neuropathy on ddI = or > grade 2.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Dideoxycytidine (ddC).\n\n        Required:\n\n          -  Zidovudine (AZT) for total of at least 24 weeks; and included within that time\n             period, AZT = or > 300 mg/day for 6 weeks prior to the study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "750", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000651", 
            "org_study_id": "ACTG 155", 
            "secondary_id": "11130"
        }, 
        "intervention": [
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zalcitabine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Zalcitabine", 
                "Zidovudine"
            ]
        }, 
        "keyword": [
            "Zalcitabine", 
            "Antiviral Agents", 
            "Zidovudine"
        ], 
        "lastchanged_date": "March 28, 2012", 
        "link": {
            "description": "Click here for more information about Zidovudine", 
            "url": "http://aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=4"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA CARE Center CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "USC CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "UCSD Maternal, Child, and Adolescent HIV CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Ucsd, Avrc Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Ucsf Aids Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }, 
                    "name": "Harbor-UCLA Med. Ctr. CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "University of Colorado Hospital CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "Univ. of Miami AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "Northwestern University CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "Rush Univ. Med. Ctr. ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana Univ. School of Medicine, Infectious Disease Research Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Tulane Hemophilia Treatment Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins Adult AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "Brigham and Women's Hosp., Div. of Infectious Disease"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Deaconess Med. Ctr., ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Bmc Actg Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "HMS - Children's Hosp. Boston, Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Beth Israel Deaconess - East Campus A0102 CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota, ACTU"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "St. Louis ConnectCare, Infectious Diseases Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Washington U CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newark", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07103"
                    }, 
                    "name": "NJ Med. School CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14215"
                    }, 
                    "name": "SUNY - Buffalo, Erie County Medical Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "NY Univ. HIV/AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Beth Israel Med. Ctr. (Mt. Sinai)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Cornell University A2201"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "NYU Med. Ctr., Dept. of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Univ. of Rochester ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599"
                    }, 
                    "name": "Unc Aids Crs"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "Carolinas HealthCare System, Carolinas Med. Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke Univ. Med. Ctr. Adult CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greensboro", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "Regional Center for Infectious Disease, Wendover Medical Center CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45267"
                    }, 
                    "name": "Univ. of Cincinnati CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106"
                    }, 
                    "name": "Case CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }, 
                    "name": "The Ohio State Univ. AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }, 
                    "name": "Pitt CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98122"
                    }, 
                    "name": "University of Washington AIDS CRS"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy", 
        "overall_official": [
            {
                "last_name": "M Fischl", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "A Collier", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "reference": [
            {
                "PMID": "8780079", 
                "citation": "Blum AS, Dal Pan GJ, Feinberg J, Raines C, Mayjo K, Cornblath DR, McArthur JC. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors. Neurology. 1996 Apr;46(4):999-1003."
            }, 
            {
                "PMID": "7552481", 
                "citation": "Fichtenbaum CJ, Clifford DB, Powderly WG. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):169-74."
            }, 
            {
                "citation": "Fischl M, Collier A, Stanley K, Ardunio JM, Kazial K, Stein D. The safety and efficacy of zidovudine (ZDV) and zalcitabine (ddC) or ddC alone versus ZDV. ACTG 155 Team of the NIAID. Int Conf AIDS. 1993 Jun 6-11;9(1):68 (abstract no WS-B25-1)"
            }, 
            {
                "citation": "Keruly J, Kendig N, Feinberg J, Cotton S, Biggs M, Benjamin Y, Francis H, Wade W, Coplin M, Bartlett J. A model for conducting AIDS clinical trials in a state correctional system. Int Conf AIDS. 1992 Jul 19-24;8(2):B236 (abstract no PoB 3873)"
            }, 
            {
                "PMID": "7811541", 
                "citation": "Johnson VA. Combination therapy: more effective control of HIV type 1? AIDS Res Hum Retroviruses. 1994 Aug;10(8):907-12. Review."
            }, 
            {
                "PMID": "7985892", 
                "citation": "Fischl MA, Stanley K, Collier AC, Arduino JM, Stein DS, Feinberg JE, Allan JD, Goldsmith JC, Powderly WG. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group. Ann Intern Med. 1995 Jan 1;122(1):24-32."
            }, 
            {
                "PMID": "9342254", 
                "citation": "Spino C, Kahn JO, Dolin R, Phair JP. Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):346-55."
            }, 
            {
                "PMID": "10843534", 
                "citation": "Zackin RA, Clark RA, Currier JS, Mildvan D. Predictive markers of HIV-related weight loss and determination of differences between populations with weight loss stratified by opportunistic processes. J Acquir Immune Defic Syndr. 1999 Oct 1;22(2):189-93."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000651"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Hoffmann-La Roche", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Glaxo Wellcome", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "Beth Israel Deaconess - East Campus A0102 CRS": "42.358 -71.06", 
        "Beth Israel Deaconess Med. Ctr., ACTG CRS": "42.358 -71.06", 
        "Beth Israel Med. Ctr. (Mt. Sinai)": "40.714 -74.006", 
        "Bmc Actg Crs": "42.358 -71.06", 
        "Brigham and Women's Hosp., Div. of Infectious Disease": "42.358 -71.06", 
        "Carolinas HealthCare System, Carolinas Med. Ctr.": "35.227 -80.843", 
        "Case CRS": "41.499 -81.695", 
        "Cornell University A2201": "40.714 -74.006", 
        "Duke Univ. Med. Ctr. Adult CRS": "35.994 -78.899", 
        "HMS - Children's Hosp. Boston, Div. of Infectious Diseases": "42.358 -71.06", 
        "Harbor-UCLA Med. Ctr. CRS": "33.836 -118.341", 
        "Indiana Univ. School of Medicine, Infectious Disease Research Clinic": "39.769 -86.158", 
        "Johns Hopkins Adult AIDS CRS": "39.29 -76.612", 
        "Massachusetts General Hospital ACTG CRS": "42.358 -71.06", 
        "Memorial Sloan-Kettering Cancer Ctr.": "40.714 -74.006", 
        "NJ Med. School CRS": "40.736 -74.172", 
        "NY Univ. HIV/AIDS CRS": "40.714 -74.006", 
        "NYU Med. Ctr., Dept. of Medicine": "40.714 -74.006", 
        "Northwestern University CRS": "41.878 -87.63", 
        "Pitt CRS": "40.441 -79.996", 
        "Regional Center for Infectious Disease, Wendover Medical Center CRS": "36.073 -79.792", 
        "Rush Univ. Med. Ctr. ACTG CRS": "41.878 -87.63", 
        "SUNY - Buffalo, Erie County Medical Ctr.": "42.886 -78.878", 
        "St. Louis ConnectCare, Infectious Diseases Clinic": "38.627 -90.199", 
        "The Ohio State Univ. AIDS CRS": "39.961 -82.999", 
        "Tulane Hemophilia Treatment Ctr.": "29.951 -90.072", 
        "Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU": "29.951 -90.072", 
        "UCLA CARE Center CRS": "34.052 -118.244", 
        "UCSD Maternal, Child, and Adolescent HIV CRS": "32.715 -117.157", 
        "USC CRS": "34.052 -118.244", 
        "Ucsd, Avrc Crs": "32.715 -117.157", 
        "Ucsf Aids Crs": "37.775 -122.419", 
        "Unc Aids Crs": "35.913 -79.056", 
        "Univ. of Cincinnati CRS": "39.103 -84.512", 
        "Univ. of Miami AIDS CRS": "25.789 -80.226", 
        "Univ. of Rochester ACTG CRS": "43.161 -77.611", 
        "University of Colorado Hospital CRS": "39.729 -104.832", 
        "University of Minnesota, ACTU": "44.98 -93.264", 
        "University of Washington AIDS CRS": "47.606 -122.332", 
        "Washington U CRS": "38.627 -90.199"
    }
}